Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

[1] Algarra I(2004)The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape Cancer Immunol Immunother 53 904-910

[2] Garcia-Lora A(2004)Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 R149-R156

[3] Cabrera T(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-2502

[4] Ruiz-Cabello F(2001)Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor Proc Natl Acad Sci USA 98 11521-11526

[5] Garrido F(2013)Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients Breast Cancer Res Treat 142 355-364

[6] Arpino G(2010)HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients J Immunol 185 7452-7459

[7] Bardou VJ(2010)The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer Clin Cancer Res 16 1272-1280

[8] Clark GM(2004)The three Es of cancer immunoediting Annu Rev Immunol 22 329-360

[9] Elledge RM(2013)The prognostic value of apoptotic and proliferative markers in breast cancer Breast Cancer Res Treat 142 323-339

[10] Carey LA(2011)Global cancer statistics CA Cancer J Clin 61 69-90

[1] Algarra I(2004)The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape Cancer Immunol Immunother 53 904-910

[2] Garcia-Lora A(2004)Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 R149-R156

[3] Cabrera T(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-2502

[4] Ruiz-Cabello F(2001)Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor Proc Natl Acad Sci USA 98 11521-11526

[5] Garrido F(2013)Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients Breast Cancer Res Treat 142 355-364

[6] Arpino G(2010)HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients J Immunol 185 7452-7459

[7] Bardou VJ(2010)The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer Clin Cancer Res 16 1272-1280

[8] Clark GM(2004)The three Es of cancer immunoediting Annu Rev Immunol 22 329-360

[9] Elledge RM(2013)The prognostic value of apoptotic and proliferative markers in breast cancer Breast Cancer Res Treat 142 323-339

[10] Carey LA(2011)Global cancer statistics CA Cancer J Clin 61 69-90